Global Newborn Screening Market Size & Outlook, 2023-2030
Global newborn screening market, 2018-2030 (US$M)
Related Markets
Global newborn screening market highlights
- The global newborn screening market generated a revenue of USD 797.5 million in 2023 and is expected to reach USD 1,308.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 7.3% by 2030.
- In terms of segment, tandem mass spectrometry accounted for a revenue of USD 196.6 million in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 797.5 million |
| Market revenue in 2030 | USD 1,308.5 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
Other key industry trends
- In terms of revenue, the North America accounted for 16.6% of the global newborn screening market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 2.2 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.65% in 2023. Horizon Databook has segmented the Global newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Extensively increasing prevalence of congenital diseases in newborns is expected to have a positive impact on the newborn screening market growth. According to a data published by WHO in February 2023, an estimated 240,000 newborns within 28 days of birth die each year globally due to congenital diseases.
In addition, according to information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2 to 7.8%. Such substantial occurrence of congenital diseases amongst newborns is likely to increase the adoption for tests, which will eventually accelerate the market growth by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global newborn screening market size, by regions, 2018-2030 (US$M)
Top 10 countries: Newborn screening market size, 2023 (US$M)
Global newborn screening market share, by technology, 2023 & 2030 (%, US$M)
Newborn screening market: Opportunity assessment by country
Global newborn screening market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
